y 27632 has been researched along with Stroke in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 1 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bayraktutan, U; Gao, X | 1 |
Jaspers, T; Lemmens, R; Robberecht, W; Thijs, VN | 1 |
Asano, T; Huang, Z; Kim, HH; Liao, JK; Moskowitz, MA; Rikitake, Y; Seto, M; Yano, K | 1 |
Guo, SZ; Kim, WJ; Lee, SR; Lo, EH; Montaner, J; Wang, S; Wang, X | 1 |
Chitaley, K; Dorrance, AM; Mills, TM; Webb, RC | 1 |
5 other study(ies) available for y 27632 and Stroke
Article | Year |
---|---|
TNF-α evokes blood-brain barrier dysfunction through activation of Rho-kinase and neurokinin 1 receptor.
Topics: Blood-Brain Barrier; Brain Ischemia; Cytokines; Endothelial Cells; Humans; Receptors, Neurokinin-1; rho-Associated Kinases; Stroke; Tumor Necrosis Factor-alpha | 2023 |
Modifying expression of EphA4 and its downstream targets improves functional recovery after stroke.
Topics: Amides; Animals; Disease Models, Animal; Gene Expression Regulation; Male; Mice; Mice, Knockout; Pyridines; Receptor, EphA4; rho-Associated Kinases; Rotarod Performance Test; Signal Transduction; Stroke; Stroke Rehabilitation | 2013 |
Inhibition of Rho kinase (ROCK) leads to increased cerebral blood flow and stroke protection.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amides; Analysis of Variance; Animals; Antihypertensive Agents; Aorta; Blotting, Northern; Blotting, Western; Brain Ischemia; Cattle; Cell Line; Cells, Cultured; Cerebrovascular Circulation; Dose-Response Relationship, Drug; Down-Regulation; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hypoxia; Infarction, Middle Cerebral Artery; Intracellular Signaling Peptides and Proteins; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Protein Serine-Threonine Kinases; Pyridines; Regional Blood Flow; rho-Associated Kinases; RNA, Messenger; Stroke; Time Factors; Umbilical Veins; Up-Regulation | 2005 |
Reduction of tissue plasminogen activator-induced matrix metalloproteinase-9 by simvastatin in astrocytes.
Topics: Amides; Animals; Astrocytes; Cells, Cultured; Cerebral Hemorrhage; Drug Evaluation, Preclinical; Enzyme Induction; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Intracellular Signaling Peptides and Proteins; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neuroprotective Agents; Protein Serine-Threonine Kinases; Pyridines; Rats; Recombinant Proteins; rho-Associated Kinases; Signal Transduction; Simvastatin; Stroke | 2006 |
Decreased penile erection in DOCA-salt and stroke prone-spontaneously hypertensive rats.
Topics: Amides; Animals; Antihypertensive Agents; Blood Pressure; Desoxycorticosterone; Electric Stimulation; Ganglia; Genetic Predisposition to Disease; Hypertension; Male; Pelvis; Penile Erection; Penis; Pyridines; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Sodium Chloride; Stroke | 2001 |